Tempus AI, Inc. – NASDAQ:TEM
Tempus AI stock price today
$70.67
+35.55
+101.22%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Tempus AI stock price monthly change
-11.67%
month
Tempus AI stock price quarterly change
-11.67%
quarter
Tempus AI key metrics
Market Cap | 5.16B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTempus AI stock price history
Tempus AI stock forecast
Tempus AI financial statements
Average Price Target
$58
Potential downside: -17.92%
Analysts Price target
Financials & Ratios estimates
| 2020 | 188.00M | -209.85M | -111.62% |
|---|---|---|---|
| 2023 | 531.82M | -214.11M | -40.26% |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 0.08% |
|---|---|
| 2020 | 0.08% |
| 2021 | 0.08% |
| 2022 | 0.08% |
| 2023 | 0.09% |
| 2023 | 564052000 | 1.94B | 345.04% |
|---|
| 2023 | -214.33M | -40.31M | 117.54M |
|---|
Tempus AI alternative data
| Dec 2024 | 2,300 |
|---|
Tempus AI other data
Tempus AI: A Good Story At A Steep Price - Hold Until It Grows Into It
Tempus AI: Sustaining Growth Momentum With Acquisitions & Partnerships
Tempus AI: High-Growth And High-Risk
Tempus AI Is Well Worth Its Price Tag
I'm Still Bullish On Tempus AI
Tempus AI: Firing On All Cylinders
Tempus AI: I Believe In The Company's Cause
GeneDx: Time To Buy The Dip
Tempus AI: Cooldown Arrived (Rating Upgrade)
-
What's the price of Tempus AI stock today?
One share of Tempus AI stock can currently be purchased for approximately $70.67.
-
When is Tempus AI's next earnings date?
Unfortunately, Tempus AI's (TEM) next earnings date is currently unknown.
-
Does Tempus AI pay dividends?
No, Tempus AI does not pay dividends.
-
How much money does Tempus AI make?
Tempus AI has a market capitalization of 5.16B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 182.88% to 531.82M US dollars.
-
What is Tempus AI's stock symbol?
Tempus AI, Inc. is traded on the NASDAQ under the ticker symbol "TEM".
-
What is Tempus AI's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Tempus AI?
Shares of Tempus AI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Tempus AI have?
As Dec 2024, Tempus AI employs 2,300 workers.
-
When Tempus AI went public?
Tempus AI, Inc. is publicly traded company for more then 13 years since IPO on 28 Mar 2012.
-
What is Tempus AI's official website?
The official website for Tempus AI is tempus.com.
-
Where are Tempus AI's headquarters?
Tempus AI is headquartered at 600 West Chicago Avenue, Chicago, IL.
-
How can i contact Tempus AI?
Tempus AI's mailing address is 600 West Chicago Avenue, Chicago, IL and company can be reached via phone at +800 9765448.
-
What is Tempus AI stock forecast & price target?
Based on 5 Wall Street analysts` predicted price targets for Tempus AI in the last 12 months, the avarage price target is $58. The average price target represents a -17.92% change from the last price of $70.67.
Tempus AI company profile:
Tempus AI, Inc.
tempus.comExchange:
NASDAQ
Full time employees:
2,300
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
600 West Chicago Avenue
Chicago, IL 60654
Chicago, IL 60654
CIK: 0001717115
ISIN: US88023B1035
CUSIP: 71535D106
